Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1196P is a human pseudogene corresponding to a non-coding U6 small nuclear RNA (snRNA) gene sequence. U6 snRNA is a component of the spliceosome complex required for the splicing of pre-mRNA in eukaryotic cells. Pseudogenes like RNU6-1196P are non-functional remnants of gene duplication or retrotransposition events and do not encode an active RNA or protein product. They are found throughout mammalian genomes and serve as genomic markers of retrotransposition activity but have no known biological function, therapeutic relevance, or disease association[1][2][5].
None (no known mechanism of action as this is not a druggable or functional molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1196, pseudogene (RNU6-1196P).